Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
about
sameAs
Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug ResistanceNucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.Nucleoside transporters in chronic lymphocytic leukaemia.AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.Digging deep into "dirty" drugs - modulation of the methylation machinery.Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent mannerIntracellular disposition of fludarabine triphosphate in human natural killer cells.Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.Drug transporter pharmacogenetics in nucleoside-based therapies.Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition.Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies.Nucleoside transporters: biological insights and therapeutic applications.Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients.Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells.All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism.Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients.Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2).Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma.Role of nucleoside transporters in nucleoside-derived drug sensitivity.Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Characteristics of complexes between poly(propylene imine) dendrimers and nucleotides
P2860
Q27488307-E8752BC6-F42A-4DEB-A623-7FDCDAE5746DQ34025097-A4A19476-B3F8-4F1B-BCD5-412CD3E85AB8Q35066350-0A7F700A-672A-4EE8-AE68-A4BB872F63C3Q35635321-411F307C-4C7B-4FF0-8F83-843E5FE0D935Q35944653-1FF153BE-CCDA-4A52-AF36-4C89F9ECE146Q36006445-0683A3C1-DA54-4CB7-A483-71AC751A293DQ36523796-72CD588B-6705-40DD-BF17-5224C6B058C4Q36907164-59929B28-B32B-43E5-BA7A-3729314275FFQ37111568-9080EE7E-9A51-480B-9433-C873EE0C6A0EQ37424784-70E8B7E2-CBC2-4E9F-886C-2704255EAEADQ37760954-CF49E94A-812B-4618-8B54-CB91E5812F94Q37834510-E9939818-567A-4C2B-96FD-3DC4B13F49EEQ37963498-CBB019FC-CFB5-4E13-B701-F5B08D543793Q38031634-F0A6F4FA-1DA8-40C1-957A-336BE4C1C8DCQ38374457-CB515E18-000F-42CD-909C-CE70028790CBQ38920650-817B3E7D-2572-4B4C-9211-F340EA16B1B4Q40187312-8B56A017-4C6D-4E45-93B5-BAF813034F98Q42519121-922250B1-8899-41AD-B921-348B94F4FC64Q43127132-C34CBFCB-F3DA-4CBA-8287-1DADFD76E07FQ45141158-C13AFAEF-BAE9-4642-B319-2167CB7E9212Q47130749-0D7B128A-DEB4-4330-8D83-57E614E511A6Q50575119-47547D81-7ED7-45B9-85F5-965EEC359AEDQ51715690-49C1C655-E72C-4C7E-8153-1D26C1441D9AQ52323624-91C87FDF-92FD-4827-BE6A-D0348A597F48Q57777281-33E16016-AED3-4F26-B9BC-9D0E0DD9D06A
P2860
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@ast
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@en
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@nl
type
label
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@ast
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@en
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@nl
prefLabel
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@ast
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@en
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@nl
P2093
P1433
P1476
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia
@en
P2093
Beatriz Bellosillo
Emili Montserrat
F Javier Casado
Marçal Pastor-Anglada
Míriam Molina-Arcas
P304
P356
10.1182/BLOOD-2002-07-2236
P407
P577
2003-03-15T00:00:00Z